Ignite Creation Date:
2024-05-06 @ 5:28 PM
Last Modification Date:
2024-10-26 @ 2:30 PM
Study NCT ID:
NCT05328765
Status:
RECRUITING
Last Update Posted:
2024-07-05
First Post:
2022-04-05
Brief Title:
A Global Record of Patients With Anal Squamous Cell Carcinoma With and Without HIV Infection
Sponsor:
Latin American Cooperative Oncology Group
Organization:
Latin American Cooperative Oncology Group
Study Overview
Official Title:
ACTION HIV Anal Cancer TherapIes and Outcomes iNitiative for Patients Living With and Without HIV A Global Record of Patients With Anal Squamous Cell Carcinoma With and Without HIV Infection
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ACTION HIV
Brief Summary:
Due to the scarcity of data on prognostic and predictive influence on CCA epidemiological studies evaluating these factors need to be developed in patients with CCA Therefore the investigators want to evaluate the profile of patients in the real world and from various parts of the world describing prognostic factors such as CD4 dosage time of HIV infection evaluation of viral load diagnosis of AIDS geographic region of diagnosis and treatment clinical staging medications concomitant with QRT risk of drug interactions comorbidities possible impact on dose-intensity use of HAART time of use of HAART radiotherapy modality conventional 3D vs Modulated Beam Intensity IMRT response to Nigro vs CTII regimens as well as comparing clinical outcomes with patients without HIV infection
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None